159 related articles for article (PubMed ID: 21435203)
1. Diagnostic accuracy of point-of-care testing for acute coronary syndromes, heart failure and thromboembolic events in primary care: a cluster-randomised controlled trial.
Tomonaga Y; Gutzwiller F; Lüscher TF; Riesen WF; Hug M; Diemand A; Schwenkglenks M; Szucs TD
BMC Fam Pract; 2011 Mar; 12():12. PubMed ID: 21435203
[TBL] [Abstract][Full Text] [Related]
2. Multicentre analytical evaluation of a new point-of-care system for the determination of cardiac and thromboembolic markers.
Bertsch T; Chapelle JP; Dempfle CE; Giannitsis E; Schwabs M; Zerback R
Clin Lab; 2010; 56(1-2):37-49. PubMed ID: 20380358
[TBL] [Abstract][Full Text] [Related]
3. Point-of-care testing in primary care patients with acute cardiopulmonary symptoms: a systematic review.
Schols AMR; Stakenborg JPG; Dinant GJ; Willemsen RTA; Cals JWL
Fam Pract; 2018 Jan; 35(1):4-12. PubMed ID: 28985344
[TBL] [Abstract][Full Text] [Related]
4. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
[TBL] [Abstract][Full Text] [Related]
5. Prognostic assessment of elderly patients with symptoms of heart failure by combining high-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide measurements.
Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
Clin Chem; 2010 Nov; 56(11):1718-24. PubMed ID: 20844063
[TBL] [Abstract][Full Text] [Related]
6. Biomarker changes after strenuous exercise can mimic pulmonary embolism and cardiac injury--a metaanalysis of 45 studies.
Sedaghat-Hamedani F; Kayvanpour E; Frankenstein L; Mereles D; Amr A; Buss S; Keller A; Giannitsis E; Jensen K; Katus HA; Meder B
Clin Chem; 2015 Oct; 61(10):1246-55. PubMed ID: 26240298
[TBL] [Abstract][Full Text] [Related]
7. Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis.
Gravning J; Smedsrud MK; Omland T; Eek C; Skulstad H; Aaberge L; Bendz B; Kjekshus J; Mørkrid L; Edvardsen T
Am Heart J; 2013 May; 165(5):716-24. PubMed ID: 23622908
[TBL] [Abstract][Full Text] [Related]
8. Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score.
Klingenberg R; Aghlmandi S; Räber L; Gencer B; Nanchen D; Heg D; Carballo S; Rodondi N; Mach F; Windecker S; Jüni P; von Eckardstein A; Matter CM; Lüscher TF
Eur Heart J Acute Cardiovasc Care; 2018 Mar; 7(2):129-138. PubMed ID: 28029055
[TBL] [Abstract][Full Text] [Related]
9. High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide in acute heart failure: Data from the ACE 2 study.
Berge K; Lyngbakken MN; Myhre PL; Brynildsen J; Røysland R; Strand H; Christensen G; Høiseth AD; Omland T; Røsjø H
Clin Biochem; 2021 Feb; 88():30-36. PubMed ID: 33245872
[TBL] [Abstract][Full Text] [Related]
10. Multi-marker strategy of natriuretic peptide with either conventional or high-sensitivity troponin-T for acute coronary syndrome diagnosis in emergency department patients with chest pain: from the "Rule Out Myocardial Infarction using Computer Assisted Tomography" (ROMICAT) trial.
Truong QA; Bayley J; Hoffmann U; Bamberg F; Schlett CL; Nagurney JT; Koenig W; Januzzi JL
Am Heart J; 2012 Jun; 163(6):972-979.e1. PubMed ID: 22709749
[TBL] [Abstract][Full Text] [Related]
11. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.
Weber M; Bazzino O; Navarro Estrada JL; Fuselli JJ; Botto F; Perez de Arenaza D; Möllmann H; Nef HN; Elsässer A; Hamm CW
J Am Coll Cardiol; 2008 Mar; 51(12):1188-95. PubMed ID: 18355657
[TBL] [Abstract][Full Text] [Related]
12. Investigation of a multimarker approach to the initial assessment of patients with acute chest pain.
McCann CJ; Glover BM; Menown IB; Moore MJ; McEneny J; Owens CG; Smith B; Sharpe PC; Young IS; Adgey JA
Adv Ther; 2009 May; 26(5):531-4. PubMed ID: 19475367
[TBL] [Abstract][Full Text] [Related]
13. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
[TBL] [Abstract][Full Text] [Related]
14. Combined use of the novel biomarkers high-sensitivity troponin T and ST2 for heart failure risk stratification vs conventional assessment.
Lupón J; de Antonio M; Galán A; Vila J; Zamora E; Urrutia A; Bayes-Genis A
Mayo Clin Proc; 2013 Mar; 88(3):234-43. PubMed ID: 23384388
[TBL] [Abstract][Full Text] [Related]
15. A multicenter comparison of established and emerging cardiac biomarkers for the diagnostic evaluation of chest pain in the emergency department.
Bhardwaj A; Truong QA; Peacock WF; Yeo KT; Storrow A; Thomas S; Curtis KM; Foote RS; Lee HK; Miller KF; Januzzi JL
Am Heart J; 2011 Aug; 162(2):276-282.e1. PubMed ID: 21835288
[TBL] [Abstract][Full Text] [Related]
16. N-Terminal Pro B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T Levels Are Related to the Extent of Hibernating Myocardium in Patients With Ischemic Heart Failure.
Zelt JGE; Liu PP; Erthal F; deKemp RA; Wells G; O'Meara E; Garrard L; Beanlands RSB; Mielniczuk LM
Can J Cardiol; 2017 Nov; 33(11):1478-1488. PubMed ID: 28966019
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome.
Lindholm D; James SK; Bertilsson M; Becker RC; Cannon CP; Giannitsis E; Harrington RA; Himmelmann A; Kontny F; Siegbahn A; Steg PG; Storey RF; Velders MA; Weaver WD; Wallentin L;
Clin Chem; 2017 Feb; 63(2):573-584. PubMed ID: 27932413
[TBL] [Abstract][Full Text] [Related]
18. A combination of increased Rho kinase activity and N-terminal pro-B-type natriuretic peptide predicts worse cardiovascular outcome in patients with acute coronary syndrome.
Dong M; Liao JK; Yan B; Li R; Zhang M; Yu CM
Int J Cardiol; 2013 Sep; 167(6):2813-9. PubMed ID: 22921817
[TBL] [Abstract][Full Text] [Related]
19. Biomarker of Collagen Turnover (C-Terminal Telopeptide) and Prognosis in Patients With Non- ST -Elevation Acute Coronary Syndromes.
Zelniker TA; Jarolim P; Scirica BM; Braunwald E; Park JG; Das S; Sabatine MS; Morrow DA
J Am Heart Assoc; 2019 May; 8(9):e011444. PubMed ID: 31020897
[TBL] [Abstract][Full Text] [Related]
20. No Added Value of Novel Biomarkers in the Diagnostic Assessment of Patients Suspected of Acute Coronary Syndrome.
Poldervaart JM; Röttger E; Dekker MS; Zuithoff NP; Verheggen PW; de Vrey EA; Wildbergh TX; van 't Hof AW; Mosterd A; Hoes AW
PLoS One; 2015; 10(7):e0132000. PubMed ID: 26177390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
